Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and z-drugs: a systematic review.

Mokhar A, Topp J, Härter M, Schulz H, Kuhn S, Verthein U, Dirmaier J.

PeerJ. 2018 Oct 8;6:e5535. doi: 10.7717/peerj.5535. eCollection 2018.

2.

Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study.

Topp J, Augustin M, von Usslar K, Gosau R, Reich K, Reusch M, Blome C.

Acta Derm Venereol. 2019 Feb 1;99(2):211-217. doi: 10.2340/00015555-3063.

3.

Psychometric properties of the German version of Observer OPTION5.

Kölker M, Topp J, Elwyn G, Härter M, Scholl I.

BMC Health Serv Res. 2018 Jan 31;18(1):74. doi: 10.1186/s12913-018-2891-6.

4.

Shared decision-making in physical therapy: A cross-sectional study on physiotherapists' knowledge, attitudes and self-reported use.

Topp J, Westenhöfer J, Scholl I, Hahlweg P.

Patient Educ Couns. 2018 Feb;101(2):346-351. doi: 10.1016/j.pec.2017.07.031. Epub 2017 Jul 26.

PMID:
28779911
5.

Vorvida: study protocol of a randomized controlled trial testing the effectiveness of Internet-based self-help program for the reduction of alcohol consumption for adults.

Zill JM, Meyer B, Topp J, Daubmann A, Härter M, Dirmaier J.

BMC Psychiatry. 2016 Jan 29;16:19. doi: 10.1186/s12888-016-0725-9.

6.

Spin waves and domain wall modes in curved magnetic nanowires.

Bocklage L, Motl-Ziegler S, Topp J, Matsuyama T, Meier G.

J Phys Condens Matter. 2014 Jul 2;26(26):266003. doi: 10.1088/0953-8984/26/26/266003. Epub 2014 Jun 9.

PMID:
24911994
7.

Enhanced transmission through squeezed modes in a self-cladding magnonic waveguide.

Duerr G, Thurner K, Topp J, Huber R, Grundler D.

Phys Rev Lett. 2012 Jun 1;108(22):227202. Epub 2012 May 29.

PMID:
23003645
8.

Spin wave diffraction and perfect imaging of a grating.

Mansfeld S, Topp J, Martens K, Toedt JN, Hansen W, Heitmann D, Mendach S.

Phys Rev Lett. 2012 Jan 27;108(4):047204. Epub 2012 Jan 26.

PMID:
22400886
9.

Making a reconfigurable artificial crystal by ordering bistable magnetic nanowires.

Topp J, Heitmann D, Kostylev MP, Grundler D.

Phys Rev Lett. 2010 May 21;104(20):207205. Epub 2010 May 20.

PMID:
20867058
10.

Spin-wave interference in three-dimensional rolled-up ferromagnetic microtubes.

Balhorn F, Mansfeld S, Krohn A, Topp J, Hansen W, Heitmann D, Mendach S.

Phys Rev Lett. 2010 Jan 22;104(3):037205. Epub 2010 Jan 21.

PMID:
20366680
11.

A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.

Topp JD, Jackson J, Melton AA, Lynch KW.

RNA. 2008 Oct;14(10):2038-49. doi: 10.1261/rna.1212008. Epub 2008 Aug 21.

12.

Global analysis of alternative splicing during T-cell activation.

Ip JY, Tong A, Pan Q, Topp JD, Blencowe BJ, Lynch KW.

RNA. 2007 Apr;13(4):563-72. Epub 2007 Feb 16.

13.

Biochemical characterization of Alsin, a Rab5 and Rac1 guanine nucleotide exchange factor.

Topp JD, Carney DS, Horazdovsky BF.

Methods Enzymol. 2005;403:261-76.

PMID:
16473593
14.

Cross-species characterization of the ALS2 gene and analysis of its pattern of expression in development and adulthood.

Devon RS, Schwab C, Topp JD, Orban PC, Yang YZ, Pape TD, Helm JR, Davidson TL, Rogers DA, Gros-Louis F, Rouleau G, Horazdovsky BF, Leavitt BR, Hayden MR.

Neurobiol Dis. 2005 Mar;18(2):243-57.

PMID:
15686953
15.

Tissue transglutaminase autoantibodies in cord-blood from children of healthy mothers.

Ludvigsson JF, Topp JW, Ludvigsson J.

J Clin Gastroenterol. 2005 Jan;39(1):80-1. No abstract available.

PMID:
15599221
16.

Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.

Topp JD, Gray NW, Gerard RD, Horazdovsky BF.

J Biol Chem. 2004 Jun 4;279(23):24612-23. Epub 2004 Mar 19.

17.

Vps9p CUE domain ubiquitin binding is required for efficient endocytic protein traffic.

Davies BA, Topp JD, Sfeir AJ, Katzmann DJ, Carney DS, Tall GG, Friedberg AS, Deng L, Chen Z, Horazdovsky BF.

J Biol Chem. 2003 May 30;278(22):19826-33. Epub 2003 Mar 24.

18.

Rationales, obstacles and strategies for local outcome monitoring systems in substance abuse treatment settings.

Brown TG, Topp J, Ross D.

J Subst Abuse Treat. 2003 Jan;24(1):31-42. Review.

PMID:
12646328
19.

A role for calcium in stabilizing transport vesicle coats.

Ahluwalia JP, Topp JD, Weirather K, Zimmerman M, Stamnes M.

J Biol Chem. 2001 Sep 7;276(36):34148-55. Epub 2001 Jul 2.

20.

Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.

Strassburg CP, Kneip S, Topp J, Obermayer-Straub P, Barut A, Tukey RH, Manns MP.

J Biol Chem. 2000 Nov 17;275(46):36164-71.

21.

Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome.

Kalff-Suske M, Wild A, Topp J, Wessling M, Jacobsen EM, Bornholdt D, Engel H, Heuer H, Aalfs CM, Ausems MG, Barone R, Herzog A, Heutink P, Homfray T, Gillessen-Kaesbach G, König R, Kunze J, Meinecke P, Müller D, Rizzo R, Strenge S, Superti-Furga A, Grzeschik KH.

Hum Mol Genet. 1999 Sep;8(9):1769-77.

PMID:
10441342
22.

Harm reduction: concepts and practice. A policy discussion paper.

Riley D, Sawka E, Conley P, Hewitt D, Mitic W, Poulin C, Room R, Single E, Topp J.

Subst Use Misuse. 1999 Jan;34(1):9-24.

PMID:
10052387
23.
24.

Intubation via the LMA using a Cook retrograde intubation kit.

Arndt GA, Topp J, Hannah J, McDowell TS, Lesko A.

Can J Anaesth. 1998 Mar;45(3):257-60.

PMID:
9579265
25.
26.

Breastfeeding and birth control.

Dwyer R, Potter C, Wright C, Smith M, Topp J, Holmes W.

Lancet. 1991 Jun 8;337(8754):1415. No abstract available.

PMID:
1674787
28.

[Resolution of the problems. Interview by Iwona Krysiak].

Zdrojewska I, Topp J.

Pieleg Polozna. 1985;(7-8):33. Polish. No abstract available.

PMID:
3853808
29.

Hemophilus aphrophilus endocarditis with a probable primary dental focus of infection.

Root TE, Silva EA, Edwards LD, Topp JH.

Chest. 1981 Jul;80(1):109-10.

PMID:
7249697
30.

Clinical and roentgenographic aspects of pseudogout: a study of 50 cases and a review.

Fam AG, Topp JR, Stein HB, Little AH.

Can Med Assoc J. 1981 Mar 1;124(5):545-51. Review.

31.

Treatment of persistent knee effusions with intra-articular radioactive gold.

Topp JR, Cross EG, Fam AG.

Can Med Assoc J. 1975 May 3;112(9):1085-9.

32.

Treatment of Reiter's syndrome with methotrexate.

Topp JR, Fam AG, Hart GD.

Can Med Assoc J. 1971 Dec 4;105(11):1168-9 passim. No abstract available.

33.
34.

Widespread necrotizing arteritis in rheumatoid arthritis: report of a patient who survived.

Topp JR, Hart GD.

Can Med Assoc J. 1967 Aug 19;97(8):412-5. No abstract available.

35.

Paroxysmal nocturnal hemoglobinuria. A review and report of an unusual case.

TOPP JR, HART GD.

Can Med Assoc J. 1961 Dec 23;85:1385-9. No abstract available.

36.

Pruritus of pregnancy, a symptom of hepatic dysfunction, with a report of two cases.

TOPP JR, CHARLES B.

Can Med Assoc J. 1961 Sep 23;85:724-6. No abstract available.

37.

A device for measuring the mean electrical axis of the heart.

TOPP JH, ROSENBAUM FF.

Am Heart J. 1949 Jul;38(1):130-4. No abstract available.

PMID:
18145875
38.

Needle biopsy of the liver.

TOPP JH, LINDERT MC, MURPHY FD.

Arch Intern Med (Chic). 1948 Jun;81(6):832-58. No abstract available.

PMID:
18107765
39.

The diagnosis of hemochromatosis by means of needle biopsy of the liver.

TOPP JH, LINDERT MC.

Gastroenterology. 1948 May;10(5):813-21. No abstract available.

PMID:
18860206
40.

Failure to isolate streptococci from nine cases of pemphigus.

CURTIS AC, TOPP JM.

J Invest Dermatol. 1947 Sep;9(3):151-3. No abstract available.

Supplemental Content

Support Center